--- title: "NHS National Pharmaceuticals Transition 2022_1" ocid: "ocds-h6vhtk-032338" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-032338" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-032338.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-032338.json" source: "Find A Tender Service" current_stage: "Award" buyer: "NHS ENGLAND" published: "2022-08-12" --- # NHS National Pharmaceuticals Transition 2022_1 Buyer: NHS ENGLAND Current stage: Award OCID: ocds-h6vhtk-032338 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-032338) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-032338.json) ## Summary The public procurement contracting process is currently in the Tender stage. The buying organisation is identified as [Buying Organisation]. The title of the procurement project is [Title], falling under the industry category of [Industry Category]. The location for this procurement is in [Location]. Key dates and deadlines include [Key Dates/Deadlines], providing opportunities for businesses to bid on this contract and grow their operations. This tender presents an opportunity for businesses in [Industry Category] to compete for a government contract with [Buying Organisation]. Companies specialising in [Specific Business Types] would be well-suited to engage in this procurement process. By participating in this tender, businesses can expand their market reach and establish a valuable partnership with the contracting authority, increasing their growth potential. ## Notice NHS National Pharmaceuticals Transition 2022_1 Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6months) Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22 months) Hospital Only Products: CESW: 29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22 months) NWLN: 29/07/2022 to 31/01/2023 (6 months) ### Lot Information Lot 1 - CM/PHG/21/5637/00 Transition products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637/00 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Potential periods of call-offs under the framework agreement: Transition: CESW: 29/07/2022 to30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22months) NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: Option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Lot 2 - CM/PHG/21/5637/01 Oral (plus non-parenteral) products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637/01 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Oral (plus non-parenteral) Products: All regions: 29/07/2022 to 31/05/2024 (22months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Lot 3 - CM/PHG/21/5637/02 Hospital Only Products Invitation to offer for NHS National Pharmaceuticals Transition 2022_1 Offer reference number: CM/PHG/21/5637/02 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. Hospital Only Products: CESW:29/07/2022 to 30/09/2023 (14 months) LSNE: 29/07/2022 to 31/05/2024 (22months) NWLN: 29/07/2022 to 31/01/2023 (6months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents Options: option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/022307-2022 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 12 Aug 2022 | | Submission deadline | 21 Apr 2022 | | Future notice date | Not specified | | Award date | 18 Jul 2022 | | Contract period | 30 Jun 2022 - 31 May 2024 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £467,969,000 | | Lots value | £467,969,000 | | Awards value | Not specified | | Contracts value | £1 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS ENGLAND | | Additional buyers | THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND) | | Locality | RUNCORN | | Post town | Warrington | | Postcode | WA7 2ES | | Country | England | | ITL 1 | TLE Yorkshire and The Humber | | ITL 2 | TLE4 West Yorkshire | | ITL 3 | TLE42 Leeds | | Local authority | Leeds | | Electoral ward | Little London & Woodhouse | | Westminster constituency | Leeds Central and Headingley | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 42 | | Supplier names | ACCORD-UK; ALTURIX; AMAROX; ASPEN PHARMACARE; B. BRAUN MEDICAL; CELIX PHARMA; CHIESI; CLINIGEN HEALTHCARE; CONSILIENT HEALTH; DAY LEWIS MEDICAL; DR.REDDY'S LABORATORIES (UK; ENNOGEN HEALTHCARE; FLEXIPHARM AUSTRADING; FLYNN PHARMA; FRESENIUS KABI; GLENMARK PHARMACEUTICALS EUROPE; INTRAPHARM LABORATORIES; KENT PHARMA; MACURE PHARMA; MEDAC PHARMA; MERCURY PHARMACEUTICALS; MILPHARM LTD/AUROBINBDO; MORNINGSIDE PHARMAEUTICALS; MYLAN; NAPP PHARMACEUTICALS; NEON HEALTHCARE; NORGINE PHARMACEUTICALS; PANPHARMA; PFIZER; PIRAMAL CRITICAL CARE; RANBAXY; RELONCHEM; ROCHE PRODUCTS; ROMA PHARMACEUTICALS; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; SINTETICA; TEVA; TILLOMED LABORATORIES; WOCKHARDT; ZENTIVA PHARMA | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 12 Aug 2022 at 13:39 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/022307-2022 - 17 Mar 2022 at 15:12 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/007326-2022 ## Notice URLs - http://health.atamis.co.uk - https://supplierregistration.cabinetoffice.gov.uk - https://www.england.nhs.uk/ - https://www.gov.uk/courts-tribunals ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-032338. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-032338.json.